Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe UI now displays Revision: v3.5.0 in place of Revision: v3.4.3, reflecting a minor site revision.SummaryDifference0.0%

- Check24 days agoChange DetectedFooter shows revision: v3.4.3, replacing the previous v3.4.2 tag.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded site revision tag 'Revision: v3.4.2' and removed the government funding status notice along with the earlier 'Revision: v3.4.1' entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedAdded a government funding lapse notice at the top of the page clarifying the NIH Clinical Center status, and updated the revision to v3.4.1. The previous revision v3.4.0 was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedGlossary is shown by default and metadata updates include No FEAR Act Data, Revision: v3.4.0, and Last Update Submitted that Met QC Criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedA new revision label v3.3.4 is displayed, replacing v3.3.3; the study details page content and layout appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.